QIMING U.S. VENTURES MANAGEMENT, LLC
CIK 1909617 · Holdings on Dec 31, 2023 · First reported Feb 14, 2024
Top ten holdings
Q4 2023- 45114M10950.66%
- KRRO16.15%
- TRML15.38%
- 43157M1028.21%
- JSPR6.16%
- VTYX1.55%
- 28623U1011.17%
- 49372L1000.72%
Share classes counted separately100.00%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- VTYXWeight decreased · -30.10 pp31.65% → 1.55%Shares 0 (0.00%)
- 45114M109Weight increased · +14.54 pp36.12% → 50.66%Shares 0 (0.00%)
- 43157M102Weight decreased · -1.77 pp9.98% → 8.21%Shares 0 (0.00%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 8
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | 45114M109ICOSAVAX INC View history and evidence | $55.32M | 50.66% | 3.51M shares | 36.12% → 50.66%+14.54 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | KRROKORRO BIO INC View history and evidence | $17.64M | 16.15% | 368.08K shares | Prior unavailable +368.08K | New | ↗▾ |
| 03 | TRMLTOURMALINE BIO INC View history and evidence | $16.80M | 15.38% | 641.69K shares | Prior unavailable +641.69K | New | ↗▾ |
| 04 | 43157M102HILLEVAX INC View history and evidence | $8.97M | 8.21% | 558.92K shares | 9.98% → 8.21%-1.77 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | JSPRJASPER THERAPEUTICS INC View history and evidence | $6.72M | 6.16% | 8.52M shares | 7.92% → 6.16%-1.76 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | VTYXVENTYX BIOSCIENCES INC View history and evidence | $1.70M | 1.55% | 686.37K shares | 31.65% → 1.55%-30.10 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | 28623U101ELEVATION ONCOLOGY INC View history and evidence | $1.27M | 1.17% | 2.37M shares | 2.09% → 1.17%-0.92 pp 0 (0.00%) | Unchanged | ↗▾ |
| 08 | 49372L100KEZAR LIFE SCIENCES INC View history and evidence | $785.12K | 0.72% | 828.71K shares | 1.31% → 0.72%-0.59 pp 0 (0.00%) | Unchanged | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 1
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| 87410C104 TALARIS THERAPEUTICS INC | Non-derivative | -2,932,606 | -$8.24M | SEC filing ↗ | SEC filing ↗ |
1 / 1 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1909617 · Period 2023-12-31
Data loaded 2026-09-23 · First reported 2024-02-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 109208914
}Take these holdings further.
This page includes 8 of 8 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 8 of 8 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1909617","quarter":"2023Q4","page_size":100}
get_institutional_manager_history
{"cik":"1909617","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.